4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine

C70H62ClN9O10 — CID 159399615

IUPAC4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine
SMILESCC1(C)OC(=O)N(c2ccc(C(=O)Cl)cc2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(c2ccc(C(=O)Nc3ccnc4cccnc34)cc2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(c2ccc(C(=O)O)cc2)[C@H]1c1ccccc1.Nc1ccnc2cccnc12
InChIInChI=1S/C26H22N4O3.C18H16ClNO3.C18H17NO4.C8H7N3/c1-26(2)23(17-7-4-3-5-8-17)30(25(32)33-26)19-12-10-18(11-13-19)24(31)29-21-14-16-27-20-9-6-15-28-22(20)21;1-18(2)15(12-6-4-3-5-7-12)20(17(22)23-18)14-10-8-13(9-11-14)16(19)21;1-18(2)15(12-6-4-3-5-7-12)19(17(22)23-18)14-10-8-13(9-11-14)16(20)21;9-6-3-5-10-7-2-1-4-11-8(6)7/h3-16,23H,1-2H3,(H,27,29,31);3-11,15H,1-2H3;3-11,15H,1-2H3,(H,20,21);1-5H,(H2,9,10)/t23-;2*15-;/m000./s1
InChIKeyLNEBRDGDSJIOEP-GALFBIOZSA-N
MW1224.77 g/mol
LogP14.97
Rot. Bonds10

About 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine

4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine (PubChem CID 159399615) has the molecular formula C70H62ClN9O10 and a molecular weight of 1224.77 g/mol. Its IUPAC name is 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine.

Molecular Properties

Compound Name4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine
PubChem CID159399615
Molecular FormulaC70H62ClN9O10
Molecular Weight1224.77 g/mol
Exact Mass1223.43
IUPAC Name4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine
SMILESCC1(C)OC(=O)N(c2ccc(C(=O)Cl)cc2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(c2ccc(C(=O)Nc3ccnc4cccnc34)cc2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(c2ccc(C(=O)O)cc2)[C@H]1c1ccccc1.Nc1ccnc2cccnc12
InChIInChI=1S/C26H22N4O3.C18H16ClNO3.C18H17NO4.C8H7N3/c1-26(2)23(17-7-4-3-5-8-17)30(25(32)33-26)19-12-10-18(11-13-19)24(31)29-21-14-16-27-20-9-6-15-28-22(20)21;1-18(2)15(12-6-4-3-5-7-12)20(17(22)23-18)14-10-8-13(9-11-14)16(19)21;1-18(2)15(12-6-4-3-5-7-12)19(17(22)23-18)14-10-8-13(9-11-14)16(20)21;9-6-3-5-10-7-2-1-4-11-8(6)7/h3-16,23H,1-2H3,(H,27,29,31);3-11,15H,1-2H3;3-11,15H,1-2H3,(H,20,21);1-5H,(H2,9,10)/t23-;2*15-;/m000./s1
InChIKeyLNEBRDGDSJIOEP-GALFBIOZSA-N
XLogP14.97
TPSA249.67 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds10
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001224.77
LogP ≤ 514.97
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'acid_halide', 'substructure': 'N/A'}

Analyze 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine?
The IUPAC name of 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine (CID 159399615) is 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine.
What is the SMILES notation for 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine?
The canonical SMILES for 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine is CC1(C)OC(=O)N(c2ccc(C(=O)Cl)cc2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(c2ccc(C(=O)Nc3ccnc4cccnc34)cc2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(c2ccc(C(=O)O)cc2)[C@H]1c1ccccc1.Nc1ccnc2cccnc12.
What is the InChIKey of 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine?
The InChIKey is LNEBRDGDSJIOEP-GALFBIOZSA-N. The full InChI is InChI=1S/C26H22N4O3.C18H16ClNO3.C18H17NO4.C8H7N3/c1-26(2)23(17-7-4-3-5-8-17)30(25(32)33-26)19-12-10-18(11-13-19)24(31)29-21-14-16-27-20-9-6-15-28-22(20)21;1-18(2)15(12-6-4-3-5-7-12)20(17(22)23-18)14-10-8-13(9-11-14)16(19)21;1-18(2)15(12-6-4-3-5-7-12)19(17(22)23-18)14-10-8-13(9-11-14)16(20)21;9-6-3-5-10-7-2-1-4-11-8(6)7/h3-16,23H,1-2H3,(H,27,29,31);3-11,15H,1-2H3;3-11,15H,1-2H3,(H,20,21);1-5H,(H2,9,10)/t23-;2*15-;/m000./s1.
What are the key properties of 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine?
4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine has a molecular weight of 1224.77 g/mol, XLogP of 14.97, 10 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoic acid;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]benzoyl chloride;4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide;1,5-naphthyridin-4-amine is sourced from PubChem (CID 159399615), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).